These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 524251
21. Hyperosmolar opening of the blood-brain barrier in the energy-depleted rat brain. Part 1. Permeability studies. Greenwood J, Luthert PJ, Pratt OE, Lantos PL. J Cereb Blood Flow Metab; 1988 Feb; 8(1):9-15. PubMed ID: 3123500 [Abstract] [Full Text] [Related]
22. [The effect on the tumor vessel permeability by hyperosmotic blood brain barrier disruption]. Miyagami M, Tazoe M, Kagawa Y, Tsubokawa T. No To Shinkei; 1988 Sep; 40(9):875-82. PubMed ID: 3142506 [Abstract] [Full Text] [Related]
23. Growth of human lung tumor in the brain of the nude rat as a model to evaluate antitumor agent delivery across the blood-brain barrier. Neuwelt EA, Frenkel EP, D'Agostino AN, Carney DN, Minna JD, Barnett PA, McCormick CI. Cancer Res; 1985 Jun; 45(6):2827-33. PubMed ID: 2985254 [Abstract] [Full Text] [Related]
24. Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain. Erdlenbruch B, Schinkhof C, Kugler W, Heinemann DE, Herms J, Eibl H, Lakomek M. Br J Pharmacol; 2003 Jun; 139(4):685-94. PubMed ID: 12812991 [Abstract] [Full Text] [Related]
25. Osmotic blood-brain barrier opening to IgM monoclonal antibody in the rat. Neuwelt EA, Minna J, Frenkel E, Barnett PA, McCormick CI. Am J Physiol; 1986 May; 250(5 Pt 2):R875-83. PubMed ID: 3706572 [Abstract] [Full Text] [Related]
26. Modification of the blood-brain barrier permeability following intracarotid infusion of vinorelbine. Mouchard-Delmas C, Gourdier B, Vistelle R, Wiczewski M. Anticancer Res; 1995 May; 15(6B):2593-6. PubMed ID: 8669830 [Abstract] [Full Text] [Related]
27. [ACNU delivery to malignant glioma tissue by osmotic blood brain barrier modification with intracarotid infusion of hyperosmoral mannitol]. Miyagami M, Kagawa Y, Tsubokawa T. No Shinkei Geka; 1985 Sep; 13(9):955-63. PubMed ID: 2999632 [Abstract] [Full Text] [Related]
28. WR-2721 entry into the brain across a modified blood-brain barrier. Lamperti A, Conger AD, Jenkins O, Cohen G, Rizzo A, Davis ME, Sodicoff M. Radiat Res; 1988 Aug; 115(2):303-13. PubMed ID: 2841714 [Abstract] [Full Text] [Related]
29. The effects of magnesium sulfate on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats. Kaya M, Gulturk S, Elmas I, Kalayci R, Arican N, Kocyildiz ZC, Kucuk M, Yorulmaz H, Sivas A. Life Sci; 2004 Nov 26; 76(2):201-12. PubMed ID: 15519365 [Abstract] [Full Text] [Related]
30. Reversible osmotic opening of the blood-brain barrier in mice. Fredericks WR, Rapoport SI. Stroke; 1988 Feb 26; 19(2):266-8. PubMed ID: 2449747 [Abstract] [Full Text] [Related]
31. Hepatocyte growth factor attenuates cerebral ischemia-induced increase in permeability of the blood-brain barrier and decreases in expression of tight junctional proteins in cerebral vessels. Date I, Takagi N, Takagi K, Tanonaka K, Funakoshi H, Matsumoto K, Nakamura T, Takeo S. Neurosci Lett; 2006 Oct 23; 407(2):141-5. PubMed ID: 16973272 [Abstract] [Full Text] [Related]
32. Opening blood-brain-barrier by intracarotid infusion of papaverine in treatment of malignant cerebral glioma. Xue H, Wang H, Kong L, Zhou H. Chin Med J (Engl); 1998 Aug 23; 111(8):751-3. PubMed ID: 11245034 [Abstract] [Full Text] [Related]
33. Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery. Neuwelt EA, Maravilla KR, Frenkel EP, Rapaport SI, Hill SA, Barnett PA. J Clin Invest; 1979 Aug 23; 64(2):684-8. PubMed ID: 457877 [Abstract] [Full Text] [Related]
34. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats. Erdlenbruch B, Jendrossek V, Kugler W, Eibl H, Lakomek M. Cancer Chemother Pharmacol; 2002 Oct 23; 50(4):299-304. PubMed ID: 12357304 [Abstract] [Full Text] [Related]
35. Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors. Neuwelt EA, Hill SA, Frenkel EP, Diehl JT, Maravilla KR, Vu LH, Clark WK, Rapoport SI, Barnett PA, Lewis SE, Ehle AL, Beyer CW. Cancer Treat Rep; 1981 Oct 23; 65 Suppl 2():39-43. PubMed ID: 6809316 [Abstract] [Full Text] [Related]
36. Effect of osmotic blood-brain barrier disruption on methotrexate pharmacokinetics in the dog. Neuwelt EA, Frenkel EP, Rapoport S, Barnett P. Neurosurgery; 1980 Jul 23; 7(1):36-43. PubMed ID: 6774280 [Abstract] [Full Text] [Related]
37. Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier. Neuwelt EA, Barnett PA, Bigner DD, Frenkel EP. Proc Natl Acad Sci U S A; 1982 Jul 23; 79(14):4420-3. PubMed ID: 6289301 [Abstract] [Full Text] [Related]
38. Opening of the blood-brain barrier by acute elevation of intracarotid pressure. Hardebo JE, Nilsson B. Acta Physiol Scand; 1981 Jan 23; 111(1):43-9. PubMed ID: 7223451 [Abstract] [Full Text] [Related]
39. Opening of tight junctions in cerebral endothelium. I. Effect of hyperosmolar mannitol infused through the internal carotid artery. Nagy Z, Pappius HM, Mathieson G, Hüttner I. J Comp Neurol; 1979 Jun 01; 185(3):569-78. PubMed ID: 438370 [Abstract] [Full Text] [Related]
40. Clearance of bilirubin from rat brain after reversible osmotic opening of the blood-brain barrier. Levine RL, Fredericks WR, Rapoport SI. Pediatr Res; 1985 Oct 01; 19(10):1040-3. PubMed ID: 4058976 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]